These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 999450)

  • 1. Reduced growth hormone responses to amphetamine in "endogenous" depressive patients: studies in normal, "reactive" and "endogenous" depressive, schizophrenic, and chronic alcoholic subjects.
    Langer G; Heinze G; Reim B; Matussek N
    Arch Gen Psychiatry; 1976 Dec; 33(12):1471-5. PubMed ID: 999450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clonidine on growth hormone release in psychiatric patients and controls.
    Matussek N; Ackenheil M; Hippius H; Müller F; Schröder HT; Schultes H; Wasilewski B
    Psychiatry Res; 1980 Mar; 2(1):25-36. PubMed ID: 6251501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to D-amphetamine in normal controls and in depressive patients.
    Langer G; Heinze G; Reim B; Matussek N
    Neurosci Lett; 1975 Sep; 1(3):185-9. PubMed ID: 19604784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of methylphenidate on serum growth hormone: influence of antipsychotic drugs and diagnosis.
    Janowsky DS; Leichner P; Parker D; Judd L; Huey L; Clopton P
    Arch Gen Psychiatry; 1978 Nov; 35(11):1384-9. PubMed ID: 30430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid and growth hormone responses to methylamphetamine in depressive illness.
    Checkley SA
    Psychol Med; 1979 Feb; 9(1):107-15. PubMed ID: 424478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GH response to clonidine in endogenous as compared with reactive depression.
    Checkley SA; Glass IB; Thompson C; Corn T; Robinson P
    Psychol Med; 1984 Nov; 14(4):773-7. PubMed ID: 6545412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep and growth hormone secretion in alcoholics.
    Othmer E; Daughaday WH; Goodwin DW; Levine WR; Malarkey WB; Freemon F; Halikas JA
    J Clin Psychiatry; 1982 Oct; 43(10):411-4. PubMed ID: 7118835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholism.
    Banki CM
    Acta Psychiatr Scand; 1978 Mar; 57(3):232-8. PubMed ID: 645413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response to dextroamphetamine in depressed patients and normal subjects.
    Halbreich U; Sachar EJ; Asnis GM; Quitkin F; Nathan RS; Halpern FS; Klein DF
    Arch Gen Psychiatry; 1982 Feb; 39(2):189-92. PubMed ID: 7065832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of serum calcium and magnesium in cases of endogenous depression, reactive depression schizophrenia and conversion reaction.
    Hakim AH; Bomb BS; Garg AR; Singh SV
    J Assoc Physicians India; 1975 Aug; 23(8):513-7. PubMed ID: 1194224
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphetamines, growth hormone and narcolepsy.
    Parkes JD; Debono AG; Jenner P; Walters J
    Br J Clin Pharmacol; 1977 Jun; 4(3):343-9. PubMed ID: 901702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-thyroxine index in psychotic and neurotic depression.
    Rinieris PM; Christodoulou GN; Souvatzoglou AM; Koutras DA; Stefanis CN
    Acta Psychiatr Scand; 1978 Jul; 58(1):56-60. PubMed ID: 696377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluphenazine on pituitary function in man.
    Chalmers RJ; Bennie EH; Johnson RH
    Clin Endocrinol (Oxf); 1978 Jan; 8(1):75-9. PubMed ID: 627094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to sodium valproate in chronic schizophrenia.
    Monteleone P; Maj M; Iovino M; Steardo L
    Biol Psychiatry; 1986 Jun; 21(7):588-94. PubMed ID: 3085738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine release and family history of alcoholism.
    Munro CA; McCaul ME; Oswald LM; Wong DF; Zhou Y; Brasic J; Kuwabara H; Kumar A; Alexander M; Ye W; Wand GS
    Alcohol Clin Exp Res; 2006 Jul; 30(7):1143-51. PubMed ID: 16792561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.
    Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Antonozzi I; Frajese G
    Neuropsychobiology; 1990; 23(1):15-7. PubMed ID: 2280826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.
    Wolkin A; Angrist B; Wolf A; Brodie J; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Psychopharmacology (Berl); 1987; 92(2):241-6. PubMed ID: 3110848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of growth hormone secretion during the postpartum period.
    De Leo V; Lanzetta D; D'Antona D; Latessa AM; Petraglia F
    Gynecol Obstet Invest; 1992; 33(1):31-5. PubMed ID: 1563655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone responses to hypoglycemia in postmenopausal depressed women.
    Gruen PH; Sachar EJ; Altman N; Sassin J
    Arch Gen Psychiatry; 1975 Jan; 32(1):31-3. PubMed ID: 1111475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic clearance and production rates of human growth hormone.
    Taylor AL; Finster JL; Mintz DH
    J Clin Invest; 1969 Dec; 48(12):2349-58. PubMed ID: 5355346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.